CHEK2 SIGNALING IS THE KEY REGULATOR OF OOCYTE SURVIVAL AFTER CHEMOTHERAPY
Chihiro Emori, Zachary Boucher, Ewelina Bolcun‐Filas
This study shows that inhibiting CHEK2 protects primordial oocytes from chemotherapy-induced damage, suggesting it could be used to preserve ovarian function in cancer patients.
Science Advances · Oct 20, 2023Peer-reviewedDevelopmental Biology